Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
NYSE:CRL
Price:
229.03 USD
0.54%
Market Closed
Updated:
Apr 28, 2024
Charles River Laboratories International Inc
Net Income (Common)
|
Charles River Laboratories International Inc
Net Income (Common) Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Charles River Laboratories International Inc
NYSE:CRL
|
Net Income (Common)
$474.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income (Common)
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
|
Danaher Corp
NYSE:DHR
|
Net Income (Common)
$8.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
12%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Income (Common)
$788.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
69%
|
CAGR 5-Years
39%
|
CAGR 10-Years
20%
|
See Also
What is Charles River Laboratories International Inc's Net Income (Common)?
Net Income (Common)
474.6m
USD
474.6m
USD
Based on the financial report for Dec 30, 2023, Charles River Laboratories International Inc's Net Income (Common) amounts to 474.6m USD.
What is Charles River Laboratories International Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
17%
17%
Over the last year, the Net Income (Common) growth was -2%. The average annual Net Income (Common) growth rates for Charles River Laboratories International Inc have been 9% over the past three years , 16% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
